Ditopic Receptors Based on Substituted Hexahomotrioxacalix[3]arenes
duced pressure. The residue was recrystallized from CH2Cl2/n-hexane
(1:3, v/v) to afford cone-5 (139 mg, yield 79%). M.p. 126–1278C,
1H NMR (300 MHz, CDCl3): dH =1.16–1.24 (m, 18H; NCH2CH3), 3.32
(q, J=6.0 Hz, 6H; NCH2CH3), 3.43 (q, J=6.0 Hz, 6H; NCH2CH3), 4.55
(s, 6H; ArOCH2), 4.70 (d, J=13.8 Hz; ArCH2(eq)O), 4.82 (d, J=13.8 Hz;
ArCH2(ax)O), 7.95 ppm (s, 6H; ArH).
PhHb), 8.16 ppm (3H, s, NH); 13C NMR(75 MHz, CDCl3): d=12.94,
14.05, 40.08, 40.88, 68.82, 72.17, 115.01, 115.30, 122.69, 122.79, 129.03,
130.90, 132.41, 134.07, 158.60, 166.05, 166.88 ppm; FAB-MS: m/z 1309.46
[M]+; elemental analysis calcd. (%) for C66H69O12N6F9 (1309.27): C 60.55,
H 5.31, N 6.42; found: C 60.25, H 5.36, N 6.28.
Determination of the Association Constants
The association constants were determined by using 1H NMR titration
experiments in a constant concentration of host receptor (3ꢁ10À3 m) and
varying the guest concentration (0–10ꢁ10À3 m). The 1H NMR chemical
shift of the amide protons (NH) signal was used as a probe. The associa-
tion constant (Ka) for the complexes of cone-7 were calculated by non-
linear curve-fitting analysis of the observed chemical shifts of the NH
protons according to the literature procedure.[19]
Synthesis of 7,15,23–Tris(4-methylphenylaminocarbonyl)-25,26,27-tris-
(N,N-diethylaminocarbonylmethoxy)-2,4,10,12,18,20-hexahomo-3,11,19-
trioxacalix[3]arene (cone-7b)
A solution of dicyclohexylcarbodiimide (DCC; 190 mg, 0.92 mmol) in
CH2Cl2 (5 mL) was added dropwise at 08C to a solution of cone-5
(100 mg, 0.11 mmol), p-toluidine (6b; 130 mg, 1.17 mmol) and 1-hydroxy-
benzotriazole (HOBt; 26 mg, 0.17 mmol) in CH2Cl2 (12 mL). The reac-
tion mixture was stirred for 15 h at RT, then condensed under reduced
pressure. The residue was extracted with EtOAc (2ꢁ30 mL); the com-
bined extracts were washed with 10% citric acid (2ꢁ20 mL), 5% sodium
bicarbonate (20 mL), water (20 mL), and saturated brine (20 mL); the so-
lution was dried (Na2SO4) and condensed under reduced pressure. The
residue was recrystallized from MeOH to give cone-7b (64 mg, 49%) as
colorless prisms. M.p. 186–1888C; IR (KBr): n˜ =2977, 2929, 1644, 1519,
1H NMR Titration Experiments
A solution of Bu4NX (X=Cl, Br) in CDCl3/CD3CN (10:1, v/v, 0–9ꢁ
10À3 m) in the presence or absence of LiClO4 and NaClO4 was added to a
CDCl3/CD3CN (10:1, v/v, 3ꢁ10À3 m) solution of cone-7 in an NMR tube.
1H NMR spectra were recorded after addition of the reactants and the
1
temperature of the NMR probe was kept constant at 278C. The H NMR
1477, 1456, 1323, 1190, 1093, 1072, 1054, 904, 823, 667, 513 cmÀ1
.
data of the most-representative complexes are given below:
1H NMR (300 MHz, CDCl3): dH =1.12–1.23 (m, 18H; NCH2CH3), 2.25
(9H, s; PhCH3), 3.31 (q, J=7.14 Hz, 6H; NCH2CH3), 3.38 (q, J=
7.14 Hz, 6H; NCH2CH3), 4.55 (d, J=12.6 Hz; ArCH2(eq)O), 4.67 (s, 6H;
ArOCH2), 5.06 (d, J=12.6 Hz; ArCH2(ax)O), 7.03 (d, J=8.25 Hz, 6H;
PhHa), 7.25 (d, J=11.9 Hz, 6H; PhHb), 7.27 (s, 6H; ArH), 7.73 ppm (3H,
s, NH). 13C NMR (75 MHz, CDCl3): d=12.73, 14.00, 20.65, 40.06, 40.08,
68.98, 72.03, 120.99, 129.04, 129.12, 131.04, 132.20, 133.84, 135.12, 158.58,
166.04, 167.05 ppm. FAB-MS: m/z 1147.53 [M]+; elemental analysis calcd.
(%) for C66H78O12N6 (1147.36): C 69.09, H 6.85, N 7.32; found: C 68.79,
H 7.00, N 7.45.
cone-7bꢀLi+: (CDCl3/CD3CN, 10:1, v/v): dH =1.15–1.24 (m, 18H;
NCH3), 2.26 (9H, s; PhCH3), 3.17 (q, 6H; NCH2), 3.49 (q, 6H; NCH2),
4.55 (d, 6H; ArCH2(eq)O), 4.69 (s, 6H; ArOCH2), 4.80 (d, 6H;
ArCH2(ax)O), 6.89(d, 6H; PhHa), 7.36 (d, 6H; PhHb), 7.61(s, 6H; ArH),
8.74 ppm (3H, s, NH).
ClÀꢁ[cone-7bꢀLi+]: (CDCl3/CD3CN, 10:1, v/v): dH =1.12–1.23 (m, 18H;
NCH3), 2.25 (9H, s; PhCH3), 3.18 (q, 6H; NCH2), 3.49 (q, 6H; NCH2),
4.57 (d, 6H; ArCH2(eq)O), 4.68 (s, 6H; ArOCH2), 4.79 (d, 6H;
ArCH2(ax)O), 6.87 (d, 6H; PhHa), 7.37 (d, 6H; PhHb), 7.62 (s, 6H; ArH),
8.97 ppm (3H, s; NH).
BrÀꢁ[cone-7bꢀLi+]: (CDCl3/CD3CN, 10:1, v/v): dH =1.12–1.23 (m, 18H;
NCH3), 2.25 (9H, s; PhCH3), 3.18 (q, J=7.1 Hz; NCH2), 3.48 (q, 6H;
NCH2), 4.56 (d, 6H; ArCH2(eq)O), 4.68 (s, 6H; ArOCH2), 4.77 (d, 6H;
ArCH2(ax)O), 6.88 (d, 6H; PhHa), 7.41 (d, 6H; PhHb), 7.73 (s, 6H; ArH),
8.87 ppm (3H, s; NH).
cone-7cꢀLi+: (CDCl3/CD3CN, 10:1, v/v): dH =1.17–1.24 (m, 18H; NCH3),
3.20 (q, 6H; NCH2), 3.51 (q, 6H; NCH2), 4.52 (d, 6H, ArCH2(eq)O), 4.69
(s, 6H, ArOCH2), 4.80 (d, 6H; ArCH2(ax)O), 6.88 (t, 6H; PhHa), 7.37(d,
6H; PhHb), 7.62(s, 6H; ArH), 8.74 ppm (3H, s; NH).
cone-7cꢀNa+: (CDCl3/CD3CN, 10:1, v/v): dH =1.17–1.24 (m, 18H;
NCH3), 3.23 (q, 6H; NCH2), 3.54 (q, 6H; NCH2), 4.64 (d, 6H; Ar-
CH2(eq)O), 4.69 (s, 6H; ArOCH2), 4.75 (d, 6H; ArCH2(ax)O), 6.93 (t, 6H;
PhHa), 7.31 (d, 6H; PhHb), 7.47 (s, 6H; ArH), 8.98 ppm (3H, s; NH).
ClÀꢁ[cone-7cꢀLi+]: (CDCl3/CD3CN, 10:1, v/v): dH =1.17–1.25 (m, 18H;
NCH3), 3.20 (q, 6H; NCH2), 3.51 (q, 6H; NCH2), 4.58 (d, 6H; Ar-
CH2(eq)O), 4.67 (s, 6H; ArOCH2), 4.74 (d, 6H; ArCH2(ax)O), 6.70 (t, 6H;
PhHa), 7.41 (d, 6H; PhHb), 7.57 (s, 6H; ArH), 8.93 ppm (3H, s; NH).
cone-7cꢀClÀ: (CDCl3/CD3CN, 10:1, v/v): dH =1.17–1.23 (m, 18H;
NCH3), 3.27 (q, 6H; NCH2), 3.40 (q, 6H; NCH2), 4.57 (d, 6H; Ar-
CH2(eq)O), 4.70 (s, 6H; ArOCH2), 5.04 (d, 6H; ArCH2(ax)O), 6.83 (t, 6H;
PhHa), 7.44 (d, 6H; PhHb), 7.43 (s, 6H; ArH), 8.01 ppm (3H, s; NH).
BrÀꢁ[cone-7cꢀLi+]: (CDCl3/CD3CN, 10:1, v/v): dH =1.17–1.23 (m, 18H;
NCH3), 3.19 (q, 6H; NCH2), 3.50 (q, 6H; NCH2), 4.61 (d, 6H; Ar-
CH2(eq)O), 4.69 (s, 6H; ArOCH2), 4.76 (d, 6H; ArCH2(ax)O), 6.75 (t, 6H;
PhHa), 7.58 (d, 6H; PhHb), 7.80 (s, 6H; ArH), 8.57 ppm (3H, s; NH).
cone-7cꢀBrÀ: (CDCl3/CD3CN, 10:1, v/v): dH =1.17–1.24 (m, 18H;
NCH3), 3.29 (q, 6H; NCH2), 3.42 (q, 6H; NCH2), 4.57 (d, 6H; Ar-
CH2(eq)O), 4.70 (s, 6H; ArOCH2), 5.06 (d, 6H; ArCH2(ax)O), 6.95 (t, 6H;
PhHa), 7.24 (d, 6H; PhHb), 7.32 (s, 6H; ArH) and 7.96 ppm (3H, s; NH).
Similarly, compounds cone-7a, cone-7c, and cone-7d were synthesized as
described above in 52, 57, and 62% yields, respectively.
7,15,23-Tris(phenylaminocarbonyl)-25,26,27-tris(N,N-diethylaminocarbo-
nylmethoxy)-2,4,10,12,18,20-hexahomo-3,11,19-trioxacalix[3]arene (cone-
7a) was obtained as colorless prisms. M.p. 204–2058C; IR (KBr): n˜ =
2931, 1650, 1560, 1540, 1504, 1452, 1052, 809, 667 cmÀ1
;
1H NMR
(300 MHz, CDCl3): dH =1.13–1.23 (m, 18H; NCH2CH3), 3.31–3.44 (m,
12H; NCH2), 4.54 (d, J=12.6 Hz, 6H; ArCH2(eq)O), 4.68 (s, 6H;
ArOCH2), 5.03 (d, J=13.2 Hz, 6H; ArCH2(ax)O), 7.04–7.40 (m, 15H;
ArH), 7.32 (s, 6H; ArH), 7.96 ppm (3H, s; NH); 13C NMR(75 MHz,
CDCl3): d=12.97, 14.30, 40.16, 41.00, 69.28, 72.11, 120.92, 124.43, 128.78,
129.16, 131.19, 132.57, 137.86, 158.84, 166.09, 166.89 ppm; FAB-MS: m/z
1105.53 [M]+; elemental analysis calcd. (%) for C63H72O12N6 (1105.28):
C 68.46, H 6.57, N 7.60; found: C 68.18, H 6.28, N 7.66.
7,15,23-Tris(4-fluorophenylaminocarbonyl)-25,26,27-tris-(N,N-diethylami-
nocarbonylmethoxy)-2,4,10,12,18,20-hexahomo-3,11,19-trioxacalix[3]ar-
ene (cone-7c) was obtained as colorless prisms. M.p. 237–2388C; IR
(KBr): n˜ =2959, 2863, 1689, 1602, 1537, 1483, 1445, 1363, 1311, 1198,
1068, 879, 754, 693, 503 cmÀ1; 1H NMR (300 MHz, CDCl3): dH =1.17–1.22
(m, 18H; NCH3), 3.29 (q, J=7.14 Hz, 6H; NCH2), 3.40 (q, J=7.14 Hz,
6H; NCH2), 4.58 (d, J=13.0 Hz; ArCH2(eq)O), 4.67 (s, 6H; ArOCH2),
4.99 (d, J=13.0 Hz; ArCH2(ax)O), 6.88 (t, J=8.82 Hz, 6H; PhHa), 7.33 (t,
J=6.9 Hz, 6H; PhHb), 7.35 (s, 6H; ArH), 8.07 ppm (3H, s; NH);
13C NMR (75 MHz, CDCl3): d=12.94, 14.28, 40.16, 41.00, 69.42, 72.19,
108.25, 114.10, 119.87, 124.50, 128.49, 132.66, 133.44, 143.14, 161.53,
161.83, 166.45 ppm. FAB-MS: m/z 1159.45 [M]+; elemental analysis calcd.
(%) for C63H69O12N6F3 (1159.25): C 65.27, H 6.00, N 7.25; found: C 65.55,
H 6.28, N 7.28.
7,15,23-Tris(4-trifluoromethylphenylaminocarbonyl)-25,26,27-tris-(N,N-di-
ethylaminocarbonylmethoxy)-2,4,10,12,18,20-hexahomo-3,11,19-trioxaca-
lix[3]arene (cone-7d) was obtained as colorless prisms. M.p. 273–2748C;
IR (KBr): n˜ =2974, 2931, 1789, 1652, 1477, 1458, 1439, 1309, 1161, 1092,
Crystallographic Analysis of cone-7c
1074, 742 cmÀ1 1H NMR (300 MHz, CDCl3): dH =1.14–1.25 (m, 18H;
.
Crystal data: C63H69F3N6O12; Mr =1159.2; monoclinic; space group: P21/n
(equiv to no. 14); a=20.9753(3), b=12.9216(2), c=22.2116(3) ꢂ; b=
NCH2CH3), 3.37 (q, 12H, J=7.8 Hz; NCH2), 4.63 (d, J=13.2 Hz, 6H;
ArCH2(eq)O), 4.67 (s, 6H; ArOCH2), 4.97 (d, J=13.2 Hz; ArCH2(ax)O),
7.38 (d, J=8.4 Hz, 6H; PhHa), 7.43 (s, 6H; ArH), 7.49 (d, J=8.4 Hz, 6H;
Chem. Asian J. 2012, 7, 519 – 527
ꢀ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
525